1
|
Vieira SAPB, Dos Santos BM, Santos Júnior CD, de Paula VF, Gomes MSR, Ferreira GM, Gonçalves RL, Hirata MH, da Silva RA, Brandeburgo MIH, Mendes MM. Isohemigossypolone: Antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl. Comp Biochem Physiol C Toxicol Pharmacol 2021; 245:109028. [PMID: 33676005 DOI: 10.1016/j.cbpc.2021.109028] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2021] [Revised: 02/16/2021] [Accepted: 02/23/2021] [Indexed: 01/17/2023]
Abstract
We investigated the antiophidic properties of isohemigossypolone (ISO), a naphthoquinone isolated from the outer bark of the Pachira aquatic Aubl. The inhibition of phospholipase A2, coagulant, fibrinogenolytic, hemorrhagic and myotoxic activities induced by Bothrops pauloensis venom (Pb) was investigated. For this, we use samples resulting from the incubation of Pb with ISO in different concentrations (1:1, 1:5 and 1:10 w/w), we also evaluated the condition of treatment using ISO after 15 min of venom inoculation. The activities of phospholipase A2, coagulant, fibrinogenolytic, hemorrhagic and myotoxic induced by the B. pauloensis venom were significantly inhibited when the ISO was pre-incubated with the crude venom. For in vivo neutralization tests, the results were observed even when the ISO was applied after 15 min of inoculation of the venom or metalloprotease (BthMP). Also, to identify the inhibition mechanism, we performed in silico assays, across simulations of molecular coupling and molecular dynamics, it was possible to identify the modes of interaction between ISO and bothropic toxins BmooMPα-I, Jararacussin-I and BNSP-7. The present study shows that naphthoquinone isohemigossypolone isolated from the P. aquatica plant inhibited part of the local and systemic damage caused by venom proteins, demonstrating the pharmacological potential of this compound in neutralizing the harmful effects caused by snakebites.
Collapse
Affiliation(s)
| | - Benedito Matheus Dos Santos
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil
| | - Célio Dias Santos Júnior
- Institute of Genetics and Biochemistry, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Vanderlúcia Fonseca de Paula
- Laboratory of Natural Products, Department of Sciences and Technology, State University of Bahia Southwest (UESB), Jequié, BA, Brazil
| | - Mario Sergio Rocha Gomes
- Institute of Genetics and Biochemistry, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Glaucio Monteiro Ferreira
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil
| | | | - Mario Hiroyuki Hirata
- Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil
| | | | | | - Mirian Machado Mendes
- Special Academic Unit of Biosciences, Federal University of Goiás (UFG), Jataí, GO, Brazil.
| |
Collapse
|
3
|
Souza JB, Cardoso R, Almeida-Souza HO, Carvalho CP, Correia LIV, Faria PCB, Araujo GR, Mendes MM, Rodrigues RS, Rodrigues VM, Dandekar AM, Goulart LR, Nascimento R. Generation and In-planta expression of a recombinant single chain antibody with broad neutralization activity on Bothrops pauloensis snake venom. Int J Biol Macromol 2020; 149:1241-1251. [PMID: 32035152 DOI: 10.1016/j.ijbiomac.2020.02.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Revised: 02/03/2020] [Accepted: 02/04/2020] [Indexed: 12/26/2022]
Abstract
The main systemic alterations present in bothropic envenomation are hemostasis disorders, for which the conventional treatment is based on animal-produced antiophidic sera. We have developed a neutralizing antibody against Bothrops pauloensis (B. pauloensis) venom, which is member of the genus most predominant in snakebite accidents in Brazil. Subsequently, we expressed this antibody in plants to evaluate its enzymatic and biological activities. The ability of single-chain variable fragment (scFv) molecules to inhibit fibrinogenolytic, azocaseinolytic, coagulant and hemorrhagic actions of snake venom metalloproteinases (SVMPs) contained in B. pauloensis venom was verified through proteolytic assays. The antibody neutralized the toxic effects of envenomation, particularly those related to systemic processes, by interacting with one of the predominant classes of metalloproteinases. This novel molecule is a potential tool with great antivenom potential and provides a biotechnological antidote to snake venom due to its broad neutralizing activity.
Collapse
Affiliation(s)
- Jessica B Souza
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil.
| | - Rone Cardoso
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Hebréia O Almeida-Souza
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Camila P Carvalho
- Department of Plant Pathology, University of Sao Paulo, Av. Padua Dias 11, 13418-310 Piracicaba, SP, Brazil
| | - Lucas Ian Veloso Correia
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Paula Cristina B Faria
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Galber R Araujo
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Mirian M Mendes
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Renata Santos Rodrigues
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Veridiana M Rodrigues
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| | - Abhaya M Dandekar
- Plant Sciences Department, University of California, Davis, 1 Shields Ave, Davis, CA 95616, USA
| | - Luiz Ricardo Goulart
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil.
| | - Rafael Nascimento
- Institute of Biotechnology, Federal University of Uberlandia, Av. Amazonas, Bloco 2E, Campus Umuarama, 38400-902 Uberlandia, MG, Brazil
| |
Collapse
|
4
|
Castanheira LE, Lopes DS, Gimenes SNC, Deconte SR, Ferreira BA, Alves PT, Filho LRG, Tomiosso TC, Rodrigues RS, Yoneyama KAG, Araújo FDA, Rodrigues VDM. Angiogenenic effects of BpLec, a C-type lectin isolated from Bothrops pauloensis snake venom. Int J Biol Macromol 2017; 102:153-161. [PMID: 28392382 DOI: 10.1016/j.ijbiomac.2017.04.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Revised: 03/31/2017] [Accepted: 04/04/2017] [Indexed: 12/16/2022]
Abstract
The present work reports the effects of a C-type lectin (BpLec) isolated from Bothrops pauloensis snake venom upon in vitro and in vivo angiogenesis models. Initially, we noted that BpLec was not cytotoxic to endothelial cells (tEnd) in doses up to 40μg/mL, but lower doses (2.5μg/mL, 5μg/mL, 10μg/mL and 20μg/mL) reduced tEnd cells adhesion to some extracellular matrix proteins and inhibited the in vitro vessel formation in Matrigel assay stimulated by bFGF. β-galactosides (d-lactose, N-acetyl-d-galactosamine and d-galactose) at 400mM reversed the effect of BpLec on tEnd cells adhesion, whereas d-galactose (400mM) partially reversed BpLec property of inhibiting vessel formation by tEnd cells in Matrigel. In vivo assays showed that BpLec increased hemoglobin content and capillary vessels number in polyether-polyurethane sponge discs subcutaneously implanted into dorsal skin mice. Additionally, BpLec also reduced collagen deposition and did not induce a pro-inflammatory response, as demonstrated by the decreased the secretion of some inflammatory cytokines, whereas myeloperoxidase (MPO) and N-acetylglucosaminidase (NAG) activities were not altered by BpLec. Taken together, our results indicate that BpLec might represent an interesting angiogenesis and inflammatory modulator that could also be used for searching possible therapeutic targets involved in these processes.
Collapse
Affiliation(s)
- Letícia Eulalio Castanheira
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Daiana Silva Lopes
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Sarah Natalie Cirilo Gimenes
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Simone Ramos Deconte
- Laboratório de Nanobiotecnologia, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Bruno Antônio Ferreira
- Laboratório de Nanobiotecnologia, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Patricia Terra Alves
- Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | | | - Tatiana Carla Tomiosso
- Laboratório de Nanobiotecnologia, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Renata Santos Rodrigues
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Kelly Aparecida Geraldo Yoneyama
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Fernanda de Assis Araújo
- Laboratório de Nanobiotecnologia, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Veridiana de Melo Rodrigues
- Laboratório de Bioquímica e Toxinas Animais, Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil.
| |
Collapse
|
5
|
Gomes MSR, Naves de Souza DL, Guimarães DO, Lopes DS, Mamede CCN, Gimenes SNC, Achê DC, Rodrigues RS, Yoneyama KAG, Borges MH, de Oliveira F, Rodrigues VM. Biochemical and functional characterization of Bothropoidin: the first haemorrhagic metalloproteinase from Bothrops pauloensis snake venom. J Biochem 2014; 157:137-49. [PMID: 25261583 DOI: 10.1093/jb/mvu058] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
We present the biochemical and functional characterization of Bothropoidin, the first haemorrhagic metalloproteinase isolated from Bothrops pauloensis snake venom. This protein was purified after three chromatographic steps on cation exchange CM-Sepharose fast flow, size-exclusion column Sephacryl S-300 and anion exchange Capto Q. Bothropoidin was homogeneous by SDS-PAGE under reducing and non-reducing conditions, and comprised a single chain of 49,558 Da according to MALDI TOF analysis. The protein presented an isoelectric point of 3.76, and the sequence of six fragments obtained by MS (MALDI TOF\TOF) showed a significant score when compared with other PIII Snake venom metalloproteinases (SVMPs). Bothropoidin showed proteolytic activity on azocasein, Aα-chain of fibrinogen, fibrin, collagen and fibronectin. The enzyme was stable at pH 6-9 and at lower temperatures when assayed on azocasein. Moreover, its activity was inhibited by EDTA, 1.10-phenanthroline and β-mercaptoethanol. Bothropoidin induced haemorrhage [minimum haemorrhagic dose (MHD) = 0.75 µg], inhibited platelet aggregation induced by collagen and ADP, and interfered with viability and cell adhesion when incubated with endothelial cells in a dose and time-dependent manner. Our results showed that Bothropoidin is a haemorrhagic metalloproteinase that can play an important role in the toxicity of B. pauloensis envenomation and might be used as a tool for studying the effects of SVMPs on haemostatic disorders and tumour metastasis.
Collapse
Affiliation(s)
- Mário Sérgio R Gomes
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Dayane L Naves de Souza
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Denise O Guimarães
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Daiana S Lopes
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Carla C N Mamede
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Sarah Natalie C Gimenes
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - David C Achê
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Renata S Rodrigues
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Kelly A G Yoneyama
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Márcia H Borges
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Fábio de Oliveira
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| | - Veridiana M Rodrigues
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia-MG, Brazil, Departamento de Química e Exatas, Universidade Estadual do Sudoeste da Bahia (UESB), BA, Brazil, INCT, Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica, Belo Horizonte-MG, Brazil, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (UFU), Uberlândia-MG, Brazil, Fundação Ezequiel Dias, FUNED, Belo Horizonte-MG, Brazil
| |
Collapse
|